
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Weight loss continues to be a perennial concern among patients. As many as 86% of consumers are bothered by excess weight on their body, according to a 2018 consumer survey by the American Society for Dermatologic, and that concern has ranked first for six years in a row. Research has also shown that more and more consumers are seeking out non-invasive solutions that can deliver the results they want without the barriers of cost, pain, and downtime that are typically associated with surgery, especially when it comes to addressing their aesthetic concerns. It’s no wonder then why non-surgical fat reduction was the most in-demand non-invasive body treatment among consumers in 2018.
In fact, non-invasive body contouring is the fastest-growing area of cosmetic dermatology: according to the American Society of Aesthetic Plastic Surgeons, the number of non-invasive fat reduction procedures performed tripled between 2012 to 2017. This growth shows no sign of slowing. The global non-invasive fat reduction market is expected to expand at a rate of over 15% and be valued at $2.5 billion by 2025. Moreover, the male market is growing faster than the female market, which is a rarity in aesthetics. However, this should come as no surprise since a majority of men and women are unsatisfied with their current weight, and would like to achieve a slimmer appearance, with the waist being the top source of concern for a third of all adults.
Laser modalities for non-invasive fat treatments are evolving rapidly and are the focus of much innovation. The historical application of laser in fat reduction involved low-level laser, but newer 1064 nm diode laser technology offers a significant advance over previous technologies such as cryolipolysis, ultrasound, and others.
Diode laser technology works by heating the adipose tissue layer to induce lipolysis and start apoptotic processes. Venus Bliss™, which is exemplary of the latest advances in medical aesthetic lipolysis devices, emits a 1064 nm wavelength through the applicators, which effectively passes through the skin and is absorbed by the adipose tissue layer where it heats the fat cells. The targeted fat cells release stored triglycerides, causing some to shrink and others to destruct completely. Leftover cellular debris is processed out by the body through the lymphatic system.
The treatment is completely non-invasive, which means the use of this laser lipolysis device avoids the complications that often arise with invasive procedures such as liposuction. Not only is treatment with this non-invasive lipolysis treatment device comfortable, but it also has no downtime after the treatment. In addition, it is suitable and safe for all skin types.
With all aesthetic treatments, we’ve seen that patients want high efficacy as well as comfort and the ability to improve their appearance without having to miss out on work or their regular activities. Fat reduction using diode laser technology ticks all of these boxes, delivering results quickly and safely with no downtime.
The procedure takes no more than 30 minutes, is very comfortable, and requires no downtime. A contact cooling system during treatment limits discomfort and prevents damage to the surface of the skin. Treatments can be spread out over multiple sessions for more dramatic results, with 4-6 sessions being the typical range for most patients. Most importantly, patients report treatmentsatisfaction of more than 90%.
In terms of results, one study showed a 24% reduction in fat volume when treating the abdomen and flanks, two stubborn areas for fat retention that are a top priority for patients.
A follow-up study showed an average reduction of 4.31 mm and 2.72 mm in the circumference of the flanks and abdomen respectively, and results were maintained at six months after one treatment.
Compared to cryolipolysis and other earlier modalities, Diode laser devices offers the following advantages:
Venus Concept’s comprehensive solution to target fat will enable you to offer treatments that meet your patients’ needs. With various features to enhance patient comfort, our slimming machine provides non-invasive lipolysis, resulting in fat reduction of the abdomen and flanks. Our non-invasive lipolysis treatment device appeals to patients who are looking for an alternative to liposuction, and has the ability to address a variety of in-demand body contouring needs including skin tightening* and cellulite reduction. Backed by clinically validated effectiveness, Venus Bliss™ is a comprehensive solution that allows you to deliver results for your patients and with no per-treatment usage fees for you as the provider. With the increasing demand for non-invasive fat reduction treatments, Venus Bliss™ helps you to grow your practice by offering patients the most innovative technology that is clinically proven to meet their aesthetic needs.
At Venus Concept, our comprehensive business model is designed to support your practice every step of the way. If you have any questions about the devices discussed here, including Venus Bliss™, contact us today.
*Venus Bliss™ is licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.
Venus Versa™ is licensed by Health Canada as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are licensed by Health Canada for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are licensed by Health Canada for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is licensed by Health Canada for the treatment of acne vulgaris. The DiamondPolar™ applicator is licensed by Health Canada for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is licensed by Health Canada for dermatological procedures requiring ablation and resurfacing of the skin.
NeoGraft® is licensed by Health Canada with indication for use in suction-assisted follicular extraction and re-implantation. It is an auto-graft system and can be used on both male and female patients.
ARTAS iX™ is licensed by Health Canada with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
Venus Legacy™ is licensed by Health Canada for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
The Venus Viva™ is licensed by Health Canada as a non-invasive medical aesthetic device, intended for use in dermatologic and general surgical procedures requiring ablation and resurfacing of the skin, using the Viva™/Viva™ MD applicator, and reduction in the appearance of wrinkle and rhytides in Fitzpatrick skin types I - IV using the DiamondPolar™ applicator.
Venus Epileve™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Freeze Plus™ is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction.
Venus Glow™ provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More